 | • レポートコード：GIR-107A14350 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、アダリムマブのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。アダリムマブの種類別市場規模（アダリムマブ、アダリムマブバイオシミラー）、用途別市場規模（大人、子供）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・アダリムマブの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：AbbVie、Amgen、Sandoz、Boehringer Ingelheim、Mylan、Biogen ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：アダリムマブ、アダリムマブバイオシミラー ・用途別分析2016年-2026年：大人、子供 ・アダリムマブの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・アダリムマブのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・アダリムマブのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・アダリムマブの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・アダリムマブの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Adalimumab market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Adalimumab size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Adalimumab market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Adalimumab market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Adalimumab
Adalimumab Biosimilar
Market segment by Application can be divided into
Adults
Children
The key market players for global Adalimumab market are listed below:
AbbVie
Amgen
Sandoz
Boehringer Ingelheim
Mylan
Biogen
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Adalimumab product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Adalimumab, with price, sales, revenue and global market share of Adalimumab in 2018 and 2019.
Chapter 3, the Adalimumab competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Adalimumab breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Adalimumab market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Adalimumab sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Adalimumab Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Adalimumab Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Adalimumab
1.2.3 Adalimumab Biosimilar
1.3 Market Analysis by Application
1.3.1 Overview: Global Adalimumab Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Adults
1.3.3 Children
1.4 Global Adalimumab Market Size & Forecast
1.4.1 Global Adalimumab Sales in Value (2016-2026))
1.4.2 Global Adalimumab Sales in Volume (2016-2026)
1.4.3 Global Adalimumab Price by Type (2016-2026) & (USD/Unit)
1.5 Global Adalimumab Production Capacity Analysis
1.5.1 Global Adalimumab Total Production Capacity (2016-2026)
1.5.2 Global Adalimumab Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Adalimumab Market Drivers
1.6.2 Adalimumab Market Restraints
1.6.3 Adalimumab Trends Analysis
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Adalimumab Product and Services
2.1.4 AbbVie Adalimumab Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Adalimumab Product and Services
2.2.4 Amgen Adalimumab Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Sandoz
2.3.1 Sandoz Details
2.3.2 Sandoz Major Business
2.3.3 Sandoz Adalimumab Product and Services
2.3.4 Sandoz Adalimumab Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Boehringer Ingelheim
2.4.1 Boehringer Ingelheim Details
2.4.2 Boehringer Ingelheim Major Business
2.4.3 Boehringer Ingelheim Adalimumab Product and Services
2.4.4 Boehringer Ingelheim Adalimumab Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Mylan
2.5.1 Mylan Details
2.5.2 Mylan Major Business
2.5.3 Mylan Adalimumab Product and Services
2.5.4 Mylan Adalimumab Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Biogen
2.6.1 Biogen Details
2.6.2 Biogen Major Business
2.6.3 Biogen Adalimumab Product and Services
2.6.4 Biogen Adalimumab Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Adalimumab Sales by Manufacturer
3.1 Global Adalimumab Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Adalimumab Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Adalimumab
3.4 Market Concentration Rate
3.4.1 Top 3 Adalimumab Manufacturer Market Share
3.4.2 Top 6 Adalimumab Manufacturer Market Share
3.5 Global Adalimumab Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Adalimumab Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Adalimumab Market Size by Region
4.1.1 Global Adalimumab Sales in Volume by Region (2016-2026)
4.1.2 Global Adalimumab Revenue by Region (2016-2026)
4.2 North America Adalimumab Revenue (2016-2026)
4.3 Europe Adalimumab Revenue (2016-2026)
4.4 Asia-Pacific Adalimumab Revenue (2016-2026)
4.5 South America Adalimumab Revenue (2016-2026)
4.6 Middle East and Africa Adalimumab Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Adalimumab Sales in Volume by Type (2016-2026)
5.2 Global Adalimumab Revenue by Type (2016-2026)
5.3 Global Adalimumab Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Adalimumab Sales in Volume by Application (2016-2026)
6.2 Global Adalimumab Revenue by Application (2016-2026)
6.3 Global Adalimumab Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Adalimumab Sales by Type (2016-2026)
7.2 North America Adalimumab Sales by Application (2016-2026)
7.3 North America Adalimumab Market Size by Country
7.3.1 North America Adalimumab Sales in Volume by Country (2016-2026)
7.3.2 North America Adalimumab Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Adalimumab Sales by Type (2016-2026)
8.2 Europe Adalimumab Sales by Application (2016-2026)
8.3 Europe Adalimumab Market Size by Country
8.3.1 Europe Adalimumab Sales in Volume by Country (2016-2026)
8.3.2 Europe Adalimumab Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Adalimumab Sales by Type (2016-2026)
9.2 Asia-Pacific Adalimumab Sales by Application (2016-2026)
9.3 Asia-Pacific Adalimumab Market Size by Region
9.3.1 Asia-Pacific Adalimumab Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Adalimumab Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Adalimumab Sales by Type (2016-2026)
10.2 South America Adalimumab Sales by Application (2016-2026)
10.3 South America Adalimumab Market Size by Country
10.3.1 South America Adalimumab Sales in Volume by Country (2016-2026)
10.3.2 South America Adalimumab Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Adalimumab Sales by Type (2016-2026)
11.2 Middle East & Africa Adalimumab Sales by Application (2016-2026)
11.3 Middle East & Africa Adalimumab Market Size by Country
11.3.1 Middle East & Africa Adalimumab Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Adalimumab Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Adalimumab Typical Distributors
12.3 Adalimumab Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Adalimumab Revenue by Type, (USD Million), 2021-2026
Table 2. Global Adalimumab Revenue by Application, (USD Million), 2021-2026
Table 3. AbbVie Basic Information, Manufacturing Base and Competitors
Table 4. AbbVie Major Business
Table 5. AbbVie Adalimumab Product and Services
Table 6. AbbVie Adalimumab Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Amgen Basic Information, Manufacturing Base and Competitors
Table 8. Amgen Major Business
Table 9. Amgen Adalimumab Product and Services
Table 10. Amgen Adalimumab Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Sandoz Basic Information, Manufacturing Base and Competitors
Table 12. Sandoz Major Business
Table 13. Sandoz Adalimumab Product and Services
Table 14. Sandoz Adalimumab Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 16. Boehringer Ingelheim Major Business
Table 17. Boehringer Ingelheim Adalimumab Product and Services
Table 18. Boehringer Ingelheim Adalimumab Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Mylan Basic Information, Manufacturing Base and Competitors
Table 20. Mylan Major Business
Table 21. Mylan Adalimumab Product and Services
Table 22. Mylan Adalimumab Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Biogen Basic Information, Manufacturing Base and Competitors
Table 24. Biogen Major Business
Table 25. Biogen Adalimumab Product and Services
Table 26. Biogen Adalimumab Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Global Adalimumab Sales by Manufacturer (2019-2021e) & (K Units)
Table 28. Global Adalimumab Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 29. Market Position of Manufacturers in Adalimumab, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 30. Global Adalimumab Production Capacity by Company, (K Units): 2020 VS 2021
Table 31. Head Office and Adalimumab Production Site of Key Manufacturer
Table 32. Adalimumab New Entrant and Capacity Expansion Plans
Table 33. Adalimumab Mergers & Acquisitions in the Past Five Years
Table 34. Global Adalimumab Sales by Region (2016-2021e) & (K Units)
Table 35. Global Adalimumab Sales by Region (2021-2026) & (K Units)
Table 36. Global Adalimumab Revenue by Region (2016-2021e) & (USD Million)
Table 37. Global Adalimumab Revenue by Region (2021-2026) & (USD Million)
Table 38. Global Adalimumab Sales by Type (2016-2021e) & (K Units)
Table 39. Global Adalimumab Sales by Type (2021-2026) & (K Units)
Table 40. Global Adalimumab Revenue by Type (2016-2021e) & (USD Million)
Table 41. Global Adalimumab Revenue by Type (2021-2026) & (USD Million)
Table 42. Global Adalimumab Price by Type (2016-2021e) & (USD/Unit)
Table 43. Global Adalimumab Price by Type (2021-2026) & (USD/Unit)
Table 44. Global Adalimumab Sales by Application (2016-2021e) & (K Units)
Table 45. Global Adalimumab Sales by Application (2021-2026) & (K Units)
Table 46. Global Adalimumab Revenue by Application (2016-2021e) & (USD Million)
Table 47. Global Adalimumab Revenue by Application (2021-2026) & (USD Million)
Table 48. Global Adalimumab Price by Application (2016-2021e) & (USD/Unit)
Table 49. Global Adalimumab Price by Application (2021-2026) & (USD/Unit)
Table 50. North America Adalimumab Sales by Country (2016-2021e) & (K Units)
Table 51. North America Adalimumab Sales by Country (2021-2026) & (K Units)
Table 52. North America Adalimumab Revenue by Country (2016-2021e) & (USD Million)
Table 53. North America Adalimumab Revenue by Country (2021-2026) & (USD Million)
Table 54. North America Adalimumab Sales by Type (2016-2021e) & (K Units)
Table 55. North America Adalimumab Sales by Type (2021-2026) & (K Units)
Table 56. North America Adalimumab Sales by Application (2016-2021e) & (K Units)
Table 57. North America Adalimumab Sales by Application (2021-2026) & (K Units)
Table 58. Europe Adalimumab Sales by Country (2016-2021e) & (K Units)
Table 59. Europe Adalimumab Sales by Country (2021-2026) & (K Units)
Table 60. Europe Adalimumab Revenue by Country (2016-2021e) & (USD Million)
Table 61. Europe Adalimumab Revenue by Country (2021-2026) & (USD Million)
Table 62. Europe Adalimumab Sales by Type (2016-2021e) & (K Units)
Table 63. Europe Adalimumab Sales by Type (2021-2026) & (K Units)
Table 64. Europe Adalimumab Sales by Application (2016-2021e) & (K Units)
Table 65. Europe Adalimumab Sales by Application (2021-2026) & (K Units)
Table 66. Asia-Pacific Adalimumab Sales by Region (2016-2021e) & (K Units)
Table 67. Asia-Pacific Adalimumab Sales by Region (2021-2026) & (K Units)
Table 68. Asia-Pacific Adalimumab Revenue by Region (2016-2021e) & (USD Million)
Table 69. Asia-Pacific Adalimumab Revenue by Region (2021-2026) & (USD Million)
Table 70. Asia-Pacific Adalimumab Sales by Type (2016-2021e) & (K Units)
Table 71. Asia-Pacific Adalimumab Sales by Type (2021-2026) & (K Units)
Table 72. Asia-Pacific Adalimumab Sales by Application (2016-2021e) & (K Units)
Table 73. Asia-Pacific Adalimumab Sales by Application (2021-2026) & (K Units)
Table 74. South America Adalimumab Sales by Country (2016-2021e) & (K Units)
Table 75. South America Adalimumab Sales by Country (2021-2026) & (K Units)
Table 76. South America Adalimumab Revenue by Country (2016-2021e) & (USD Million)
Table 77. South America Adalimumab Revenue by Country (2021-2026) & (USD Million)
Table 78. South America Adalimumab Sales by Type (2016-2021e) & (K Units)
Table 79. South America Adalimumab Sales by Type (2021-2026) & (K Units)
Table 80. South America Adalimumab Sales by Application (2016-2021e) & (K Units)
Table 81. South America Adalimumab Sales by Application (2021-2026) & (K Units)
Table 82. Middle East & Africa Adalimumab Sales by Country (2016-2021e) & (K Units)
Table 83. Middle East & Africa Adalimumab Sales by Country (2021-2026) & (K Units)
Table 84. Middle East & Africa Adalimumab Revenue by Country (2016-2021e) & (USD Million)
Table 85. Middle East & Africa Adalimumab Revenue by Country (2021-2026) & (USD Million)
Table 86. Middle East & Africa Adalimumab Sales by Type (2016-2021e) & (K Units)
Table 87. Middle East & Africa Adalimumab Sales by Type (2021-2026) & (K Units)
Table 88. Middle East & Africa Adalimumab Sales by Application (2016-2021e) & (K Units)
Table 89. Middle East & Africa Adalimumab Sales by Application (2021-2026) & (K Units)
Table 90. Direct Channel Pros & Cons
Table 91. Indirect Channel Pros & Cons
Table 92. Adalimumab Typical Distributors
Table 93. Adalimumab Typical Customers
List of Figures
Figure 1. Adalimumab Picture
Figure 2. Global Adalimumab Sales Market Share by Type in 2020
Figure 3. Adalimumab
Figure 4. Adalimumab Biosimilar
Figure 5. Global Adalimumab Sales Market Share by Application in 2020
Figure 6. Adults
Figure 7. Children
Figure 8. Global Adalimumab Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 9. Global Adalimumab Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. Global Adalimumab Sales (2016-2026) & (K Units)
Figure 11. Global Adalimumab Price by Type (2016-2026) & (USD/Unit)
Figure 12. Global Adalimumab Production Capacity (2016-2026) & (K Units)
Figure 13. Global Adalimumab Production Capacity by Geographic Region: 2020 VS 2021
Figure 14. Adalimumab Market Drivers
Figure 15. Adalimumab Market Restraints
Figure 16. Adalimumab Market Trends
Figure 17. Global Adalimumab Sales Market Share by Manufacturer in 2020
Figure 18. Global Adalimumab Revenue Market Share by Manufacturer in 2020
Figure 19. Adalimumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. Top 3 Adalimumab Manufacturer (Revenue) Market Share in 2020
Figure 21. Top 6 Adalimumab Manufacturer (Revenue) Market Share in 2020
Figure 22. Global Adalimumab Sales Market Share by Region (2016-2026)
Figure 23. Global Adalimumab Revenue Market Share by Region (2016-2026)
Figure 24. North America Adalimumab Revenue (2016-2026) & (USD Million)
Figure 25. Europe Adalimumab Revenue (2016-2026) & (USD Million)
Figure 26. Asia-Pacific Adalimumab Revenue (2016-2026) & (USD Million)
Figure 27. South America Adalimumab Revenue (2016-2026) & (USD Million)
Figure 28. Middle East & Africa Adalimumab Revenue (2016-2026) & (USD Million)
Figure 29. Global Adalimumab Sales Market Share by Type (2016-2026)
Figure 30. Global Adalimumab Revenue Market Share by Type (2016-2026)
Figure 31. Global Adalimumab Price by Type (2016-2026) & (USD/Unit)
Figure 32. Global Adalimumab Sales Market Share by Application (2016-2026)
Figure 33. Global Adalimumab Revenue Market Share by Application (2016-2026)
Figure 34. Global Adalimumab Price by Application (2016-2026) & (USD/Unit)
Figure 35. North America Adalimumab Sales Market Share by Type (2016-2026)
Figure 36. North America Adalimumab Sales Market Share by Application (2016-2026)
Figure 37. North America Adalimumab Sales Market Share by Country (2016-2026)
Figure 38. North America Adalimumab Revenue Market Share by Country (2016-2026)
Figure 39. United States Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Adalimumab Sales Market Share by Type (2016-2026)
Figure 43. Europe Adalimumab Sales Market Share by Application (2016-2026)
Figure 44. Europe Adalimumab Sales Market Share by Country (2016-2026)
Figure 45. Europe Adalimumab Revenue Market Share by Country (2016-2026)
Figure 46. Germany Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Adalimumab Sales Market Share by Region (2016-2026)
Figure 52. Asia-Pacific Adalimumab Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Adalimumab Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Adalimumab Revenue Market Share by Region (2016-2026)
Figure 55. China Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Korea Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Adalimumab Sales Market Share by Type (2016-2026)
Figure 62. South America Adalimumab Sales Market Share by Application (2016-2026)
Figure 63. South America Adalimumab Sales Market Share by Country (2016-2026)
Figure 64. South America Adalimumab Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East & Africa Adalimumab Sales Market Share by Type (2016-2026)
Figure 68. Middle East & Africa Adalimumab Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Adalimumab Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Adalimumab Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Egypt Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South Africa Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界の多関節若年性特発性関節炎治療薬市場 2021：企業別、地域別、種類・用途別 The Polyarticular Juvenile Idiopathic Arthritis Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain op…- 世界のインターフェロンアルファ-2bバイオシミラー市場 2021：企業別、地域別、種類・用途別 The Interferon Alpha-2b Biosimilar market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 世界の腫瘍壊死因子阻害薬市場 2021：企業別、地域別、種類・用途別 The Tumor Necrosis Factor Inhibitors Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- 世界のインターフェロンバイオシミラー市場 2021：企業別、地域別、種類・用途別 The Interferon Biosimilar market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
- 世界のリスデキサンフェタミン市場 2021：企業別、地域別、種類・用途別 The Lisdexamfetamine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, r…